SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bosco & Crossy's stock picks,talk area

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Al_Tannr who wrote (19440)6/5/2006 8:47:11 AM
From: Crossy  Read Replies (2) of 37387
 
re: QUA.PA - Quantel €25.50

Great news for Quantel holders ! US distribution base for medical lasers has been widened considerably with the following deal

biz.yahoo.com

Synergetics Announces New Three-Year Agreement to Distribute Quantel Medical Ophthalmic Lasers
Monday June 5, 8:30 am ET

O'FALLON, Mo., June 5 /PRNewswire-FirstCall/ -- Synergetics USA, Inc. (Nasdaq: SURG - News) announced today that it has signed a new three-year distribution agreement with Quantel Medical of France. Under the agreement, Synergetics will gain distribution rights in the United States and Canada for Quantel's Vitra(TM), the Company's newest ophthalmic laser. Synergetics will have exclusive distribution rights for the operating room and non-exclusive distribution rights for the ophthalmic office. The Vitra(TM) is believed to be the world's smallest, portable ophthalmic laser.
ADVERTISEMENT


"We are very excited to offer our U.S. and Canadian customers the Vitra(TM), which I consider to be the finest ophthalmic laser available," said Gregg D. Scheller, President and Chief Executive Officer of Synergetics. "Our previous venture into the laser market resulted in modest results. With this agreement, we will be able to offer our customers a truly competitive product through our existing sales organization."

"We are very proud that our new laser, The Vitra(TM), has been chosen by Synergetics," said Marc Gasnier, Chief Executive Officer of Quantel Medical. "This laser has been mainly designed to be used in the operating room, and Synergetics is a market leader in the U.S. for the devices that are used in vitreoretinal surgery. This agreement with Synergetics will give us a great opportunity to penetrate the ophthalmic laser market and should increase our market share in the U.S."

Quantel Medical is the Medical subsidiary of Quantel (EUROLIST: FR38242) a publicly-traded French company and one of the pioneers in diode - based medical lasers as well as a military laser supplier. Synergetics' prior distribution relationship with Quantel led to this new agreement.

Both companies believe the United States and Canadian markets for these types of lasers (together with related accessories) exceed $28 million annually.

About Synergetics USA, Inc.

Synergetics USA, Inc. resulted from the September 2005 combination of Valley Forge Scientific Corp. and Synergetics, Inc., bringing together their respective unique capabilities in bipolar electrosurgical generators and design, and manufacture of microsurgical hand instruments. Synergetics USA, Inc. designs, manufactures and markets medical devices for use primarily in ophthalmic surgery and neurosurgery and for other healthcare applications. Its products are designed and manufactured to support micro or minimally invasive surgical procedures. In addition to its surgical devices and equipment, it designs and manufactures disposable and non-disposable supplies and accessories for use with such devices and equipment. It also manufactures and sells bipolar electrosurgical generators and other generators, based on its DualWave(TM) technology, and complementary instrumentation and disposable products for use in neurosurgery, spine surgery, pain control and in dental applications. Synergetics sells its products primarily to hospitals, clinics and surgeons in approximately 70 countries.

About Quantel:

Founded in 1970, the QUANTEL Group has made its mark over the last ten years as a leading world specialist in laser technology for scientific, industrial and medical applications (ophthalmology, dermatology). Present in France and the United States, with its Big Sky Laser and QMInc subsidiaries, the QUANTEL Group achieved total sales of M euro 37 ($47M) in 2005, evenly distributed between scientific and industrial (52%) and medical (48%) laser applications.

Pamela G. Boone,
Chief Financial Officer
Synergetics USA, Inc.
(636)939-5100
synergeticsusa.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext